Literature DB >> 16557948

Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte.

L R Dechatelet1, M R Cooper, C E McCall.   

Abstract

The effect of the in vitro addition of colchicine on various aspects of leukocyte metabolism was investigated. Colchicine in 6 mm concentration reduced the oxygen uptake of phagocytizing leukocytes to below the level of resting cells. A similar concentration of colchicine inhibited the increase in glucose-1-(14)C oxidation by 90% and the quantitative nitroblue tetrazolium reduction by about 50%. Experiments with broken cell preparations indicate that the inhibition of the hexose monophosphate shunt is due to an inhibition of the activity of the shunt enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. In spite of these pronounced metabolic changes, the addition of 6 mm colchicine had no observable effect on the bactericidal activity of the leukocyte against three test organisms. These results support a mechanism for phagocytosis in which the hexose monophosphate-shunt activation is a secondary phenomenon which is not required for the actual killing process.

Entities:  

Year:  1971        PMID: 16557948      PMCID: PMC416108          DOI: 10.1128/iai.3.1.66-72.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood.

Authors:  S J Klebanoff; L R White
Journal:  N Engl J Med       Date:  1969-02-27       Impact factor: 91.245

2.  Colchicine plasma levels. Implications as to pharmacology and mechanism of action.

Authors:  S L Wallace; B Omokoku; N H Ertel
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

3.  The role of the phagocyte in host-parasite interactions. XX. Restoration of x-irradiation phagocytic damage by endotoxin or polyadenylic-polyuridylic acids.

Authors:  B B Paul; A A Jacobs; R R Strauss; A J Sbarra
Journal:  J Reticuloendothel Soc       Date:  1970-06

4.  Glutathione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes.

Authors:  P W Reed
Journal:  J Biol Chem       Date:  1969-05-10       Impact factor: 5.157

5.  Studies on neutrophil function. 1. Physiological and pharmacological aspects.

Authors:  R Penny; D A Galton; J T Scott; V Eisen
Journal:  Br J Haematol       Date:  1966-09       Impact factor: 6.998

6.  Suppression of metabolic accompaniments of phagocytosis by colchicine.

Authors:  S E Goldfinger; R R Howell; J E Seegmiller
Journal:  Arthritis Rheum       Date:  1965-12

7.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

8.  Leukocyte oxidase: defective activity in chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan
Journal:  Science       Date:  1967-02-17       Impact factor: 47.728

9.  The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes.

Authors:  S E Malawista; P T Bodel
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

10.  Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing.

Authors:  G L Mandell; E W Hook
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

View more
  18 in total

1.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

2.  Effect of adrenocorticosteroid on glucose metabolism in BCG-sensitized alveolar macrophages.

Authors:  C E McCall; J V Volk; M R Cooper; L R DeChatelet
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

3.  An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; L C McPhail; D Mullikin; C E McCall
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

4.  Effect of methylprednisolone on some BCG-mediated changes in rabbit alveolar macrophage.

Authors:  P Wang; R C Franson; L R DeChatelet; M Waite; C E McCall
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

5.  Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes.

Authors:  L C McPhail; L R DeChatelet; P S Shirley
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

6.  Stimulation of the hexose monophosphate shunt in human neutrophils by ascorbic acid: mechanism of action.

Authors:  L R DeChatelet; M R Cooper; C E McCall
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

7.  Concanavalin A capping in polymorphonuclear leukocytes.

Authors:  M Rister; G Brucke; F Wegener; E Gladtke
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

8.  Effects of promethazine-hydrochloride on human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; D Qualliotine-Mann; R Caldwell; C E McCall; J P Gusdon
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

9.  Polymorphonuclear leukocyte bactericidal activity and oxidative metabolism during glutathione peroxidase deficiency.

Authors:  D A Bass; L R DeChatelet; R F Burk; P Shirley; P Szejda
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

10.  Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity.

Authors:  M R Cooper; L R DeChatelet; C E McCall; M F LaVia; C L Spurr; R L Baehner
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.